How Incyte Is Advancing Clinical Trial Representation

As it relates to clinical trial diversity, it’s not for the faint of heart. It’s a work of passion and dedication, and it’s a fight that continues to be fought."
[client_name]

Leveraging Data for More Inclusive Research

Clinical trial representation is more than just a regulatory requirement—it’s a critical component of accessible healthcare. Ensuring that trial participants reflect the real-world patient population leads to more effective treatments and better health outcomes. At Incyte, a structured, data-driven approach has become the foundation for improving representation in clinical trials.In a recent discussion, Dija Atta, Head of Regional Clinical Operations, and Stacy Eckstein, Manager of Global Trial Informatics, shared how Incyte is taking meaningful steps toward more inclusive research. From launching internal initiatives to leveraging internal data and real-world data, their team is setting new standards.

Leveraging Data for More Inclusive Research

Clinical trial representation is more than just a regulatory requirement—it’s a critical component of accessible healthcare. Ensuring that trial participants reflect the real-world patient population leads to more effective treatments and better health outcomes. At Incyte, a structured, data-driven approach has become the foundation for improving representation in clinical trials.In a recent discussion, Dija Atta, Head of Regional Clinical Operations, and Stacy Eckstein, Manager of Global Trial Informatics, shared how Incyte is taking meaningful steps toward more inclusive research. From launching internal initiatives to leveraging internal data and real-world data, their team is setting new standards.

Leveraging Data for More Inclusive Research

Clinical trial representation is more than just a regulatory requirement—it’s a critical component of accessible healthcare. Ensuring that trial participants reflect the real-world patient population leads to more effective treatments and better health outcomes. At Incyte, a structured, data-driven approach has become the foundation for improving representation in clinical trials.In a recent discussion, Dija Atta, Head of Regional Clinical Operations, and Stacy Eckstein, Manager of Global Trial Informatics, shared how Incyte is taking meaningful steps toward more inclusive research. From launching internal initiatives to leveraging internal data and real-world data, their team is setting new standards.

Leveraging Data for More Inclusive Research

Clinical trial representation is more than just a regulatory requirement—it’s a critical component of accessible healthcare. Ensuring that trial participants reflect the real-world patient population leads to more effective treatments and better health outcomes. At Incyte, a structured, data-driven approach has become the foundation for improving representation in clinical trials.In a recent discussion, Dija Atta, Head of Regional Clinical Operations, and Stacy Eckstein, Manager of Global Trial Informatics, shared how Incyte is taking meaningful steps toward more inclusive research. From launching internal initiatives to leveraging internal data and real-world data, their team is setting new standards.

Leveraging Data for More Inclusive Research

Clinical trial representation is more than just a regulatory requirement—it’s a critical component of accessible healthcare. Ensuring that trial participants reflect the real-world patient population leads to more effective treatments and better health outcomes. At Incyte, a structured, data-driven approach has become the foundation for improving representation in clinical trials.In a recent discussion, Dija Atta, Head of Regional Clinical Operations, and Stacy Eckstein, Manager of Global Trial Informatics, shared how Incyte is taking meaningful steps toward more inclusive research. From launching internal initiatives to leveraging internal data and real-world data, their team is setting new standards.

Leveraging Data for More Inclusive Research

Clinical trial representation is more than just a regulatory requirement—it’s a critical component of accessible healthcare. Ensuring that trial participants reflect the real-world patient population leads to more effective treatments and better health outcomes. At Incyte, a structured, data-driven approach has become the foundation for improving representation in clinical trials.In a recent discussion, Dija Atta, Head of Regional Clinical Operations, and Stacy Eckstein, Manager of Global Trial Informatics, shared how Incyte is taking meaningful steps toward more inclusive research. From launching internal initiatives to leveraging internal data and real-world data, their team is setting new standards.

‍